Pediatric ETP-ALL patient samples have been shown to preferentially express FLT3 protein compared with non-ETP T-ALL samples [37]; however, it is not clear whether this translates to protein expression. This evidence concerns the gene FLT3 and acute lymphoblastic leukemia.